Hydrocodone Bitartrate

Products in Health Canada’s databases that list Hydrocodone Bitartrate as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.

Drug products: 28; 2 authorized now
Natural health products: 0; 0 active licences
Notices of Compliance: 13
Products in all: 28

Drug products

Authorized products first.

Name	DIN	Status	Holder	Status since
PDP-HYDROCODONE (5 MG)	02324253	Marketed	Pendopharm Division Of Pharmascience Inc	Jul 2016
DALMACOL (1.65 MG)	02230769	Dormant	Laboratoire Riva Inc.	Jul 2026
CALDOMINE DH ADULTE (5 MG)	00550485	Cancelled Post Market	Technilab Pharma Inc.	Apr 2001
CALDOMINE DH ENFANT (1.667 MG)	00550493	Cancelled Post Market	Technilab Pharma Inc.	Apr 2001
CODOFEN (7.5 MG)	02309785	Cancelled Pre Market	Paladin Pharma Inc.	Jul 2018
CORISTINE-DH LIQ (1.7 MG)	00791164	Cancelled Post Market	Technilab Pharma Inc.	Jul 2006
DALMACOL (1.65 MG)	00507407	Cancelled Post Market	Laboratoire Atlas Inc.	Apr 2025
DIMETANE EXPECTORANT DC (1.8 MG)	02244080	Cancelled Post Market	Foundation Consumer Brands, Llc	Dec 2021
DIMETANE EXPECTORANT-DC SYR (1.8 MG)	01934708	Cancelled Post Market	Whitehall-Robins Inc.	Apr 2001
HYCODAN SYRUP (5 MG)	01916580	Cancelled Post Market	Bristol-Myers Squibb Canada	Jul 2017
HYCODAN TABLETS (5 MG)	01916599	Cancelled Post Market	Bristol-Myers Squibb Canada	Aug 2017
HYCOMINE (1 MG)	01916564	Cancelled Post Market	Bristol-Myers Squibb Canada	May 2011
HYCOMINE-S (0.5 MG)	01916521	Cancelled Post Market	Bristol-Myers Squibb Canada	Oct 2009
IBUCODONE (7.5 MG)	02242018	Cancelled Pre Market	Paladin Pharma Inc.	Jul 2018
MERCODOL WITH DECAPRYN (1.65 MG)	02048183	Cancelled Post Market	Aventis Pharma Inc.	Jul 2001
NOVAHISTEX DH (5 MG)	02049481	Cancelled Post Market	Sanofi-Aventis Canada Inc.	Apr 2020
NOVAHISTEX DH EXPECTORANT (5 MG)	02049457	Cancelled Post Market	Aventis Pharma Inc.	Jul 2003
NOVAHISTINE DH (1.7 MG)	02049473	Cancelled Post Market	Sanofi-Aventis Canada Inc.	Jul 2020
RATIO-CALMYDONE (0.33 MG)	00550477	Cancelled Post Market	Teva Canada Limited	Apr 2017
RATIO-CORISTEX-DH (5 MG)	00694827	Cancelled Post Market	Ratiopharm Inc Division Of Teva Canada Limited	Aug 2015
ROBIDONE 1MG/ML SYR (1 MG)	02041677	Cancelled Post Market	Wyeth-Ayerst Canada Inc.	Nov 2001
ROBIDONE SYR 1MG/ML (1 MG)	01923366	Cancelled Post Market	Ayerst Laboratories	Aug 1997
SOLUCODAN SYRUP (2 MG)	00779512	Cancelled Post Market	Rougier Pharma Division Of Ratiopharm Inc	Sep 1999
SOLUCODAN-H (2 MG)	00779504	Cancelled Post Market	Rougier Pharma Division Of Ratiopharm Inc	Sep 1999
TRIAMINIC EXPECTORANT DH SYRUP (1.67 MG)	01906615	Cancelled Post Market	Novartis Consumer Health Canada Inc.	Apr 2001
TUSSAMINIC DH FORTE SYRUP (5 MG)	01925962	Cancelled Post Market	Novartis Consumer Health Canada Inc.	Apr 2001
TUSSAMINIC DH PEDIATRIC SYRUP (1.667 MG)	01906690	Cancelled Post Market	Novartis Consumer Health Canada Inc.	Apr 2001
VASOFRINIC DH (2.5 MG)	00472549	Cancelled Post Market	Laboratoires Trianon Inc.	Mar 2017

Notices of Compliance

Approvals of drug submissions that list it, newest first.

TUSSIONEXAugust 1, 2019 · NOC 22493
TUSSIONEXNovember 7, 2018 · NOC 21502
TUSSIONEXAugust 23, 2016 · NOC 18402
CODOFENApril 17, 2009 · NOC 10159
IBUCODONEApril 8, 2009 · NOC 10139
IBUCODONEJuly 23, 2008 · NOC 9687
CODOFENMay 21, 2008 · NOC 9558
IBUCODONEJune 1, 2007 · NOC 8808
VICOPROFENFebruary 20, 2007 · NOC 8598
TUSSIONEXMarch 29, 2006 · NOC 7846
VICOPROFENJune 13, 2001 · NOC 2313
TUSSIONEXNovember 10, 2000 · NOC 1203
VICOPROFENApril 11, 2000 · NOC 1211